Citation:Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al 1996

From Cancer Guidelines Wiki

Citation


Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996 Oct 1;78(7):1470-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/8839553.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al 1996What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al 1996 2What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al 1996 3What is the role of stereotactic radiosurgery in the treatment of brain metastases?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted
Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al 1996 4What is the clinical benefit of resection of brain metastasis?Dr Stephen Barnettcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of adjuvant whole brain radiotherapy following resection or stereotactic radiosurgery to the brain metastasis(es)</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of stereotactic radiosurgery in the treatment of brain metastases?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of stereotactic radiosurgery in the treatment of brain metastases?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the clinical benefit of resection of brain metastasis?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of resection of brain metastasis?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of resection of brain metastasis?
  2. What is the role of stereotactic radiosurgery in the treatment of brain metastases?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Mintz_AH,_Kestle_J,_Rathbone_MP,_Gaspar_L,_Hugenholtz_H,_Fisher_B,_et_al_1996&oldid=20419"